Tandem Diabetes Care Reports 2016 Financial Results

Go back to Tandem Diabetes Care Reports 2016 Financial Results

Tandem Diabetes (TNDM) Tops Q4 EPS by 17c

March 8, 2017 4:11 PM EST

Tandem Diabetes (NASDAQ: TNDM) reported Q4 EPS of ($0.48), $0.17 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $28.91 million versus the consensus estimate of $22.75 million.

GUIDANCE:

Tandem Diabetes sees FY2017 revenue of $100-107 million, versus the consensus of... More